Invega and Intestinal obstruction - a phase IV clinical study of FDA data

Summary:

Intestinal obstruction is reported as a side effect among people who take Invega (paliperidone), especially for people who are female, 40-49 old, have been taking the drug for < 1 month also take Risperdal, and have Depression.

The phase IV clinical study analyzes which people have Intestinal obstruction when taking Invega. It is created by eHealthMe based on reports of 31,960 people who have side effects when taking Invega from the FDA, and is updated regularly.

What is Invega?

Invega has active ingredients of paliperidone. It is often used in bipolar disorder. eHealthMe is studying from 32,353 Invega users. Check the latest studies of Invega.

What is Intestinal obstruction?

Intestinal obstruction is found to be associated with 1,888 drugs and 2,614 conditions by eHealthMe. Check the latest studies of Intestinal obstruction.

On Jul, 26, 2026

31,960 people reported to have side effects when taking Invega.
Among them, 61 people (0.19%) have Intestinal obstruction.

Could Invega cause Intestinal obstruction?

Among these 61 people:

How long have people been on Invega when they have Intestinal obstruction? *

What is the gender of people who have Intestinal obstruction when taking Invega? *

female: 67.24 %
male: 32.76 %

What is the age of people who have Intestinal obstruction when taking Invega? *

What are other drugs people take besides Invega? *

Invega Sustenna: 22 people, 36.07%
Risperdal: 22 people, 36.07%
Zyprexa: 21 people, 34.43%
Seroquel: 20 people, 32.79%
Abilify: 18 people, 29.51%
Anafranil: 16 people, 26.23%
Trileptal: 16 people, 26.23%
Cymbalta: 16 people, 26.23%
Paliperidone Palmitate: 16 people, 26.23%
Ludiomil: 16 people, 26.23%

What are other side effects people have besides Intestinal obstruction? *

Conjunctivitis (pink eye): 16 people, 26.23%
Psoriasis (immune-mediated disease that affects the skin): 16 people, 26.23%
Mental Disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability): 16 people, 26.23%
Eye Irritation: 16 people, 26.23%
Constipation: 16 people, 26.23%
Dry Eyes (lack of adequate tears): 16 people, 26.23%
Vision Blurred: 16 people, 26.23%
Visual Impairment: 13 people, 21.31%
Adverse Event: 12 people, 19.67%
Megacolon (a very dilated colon): 10 people, 16.39%

What are the existing conditions these people have? *

Depression: 16 people, 26.23%
Schizoaffective Disorder (a mental disorder characterized by disordered thought): 10 people, 16.39%
Constipation: 9 people, 14.75%
Schizophrenia, Paranoid Type (delusions and auditory hallucinations but relatively normal intellectual functioning and expression of affect): 5 people, 8.20%
Schizophrenia, Disorganised Type (speech and behaviour that are disorganized or difficult to understand): 4 people, 6.56%
Insomnia (sleeplessness): 4 people, 6.56%
Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 3 people, 4.92%
Psychotic Disorder: 2 people, 3.28%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 2 people, 3.28%
Extrapyramidal Disorder (involuntary muscle spasms in the face and neck): 2 people, 3.28%

* Approximation only. Some reports may have incomplete information.

Do you take Invega and have Intestinal obstruction?

- Check whether Intestinal obstruction is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Invega:

Invega (32,353 reports)

Browse all side effects of Invega:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Intestinal obstruction:

Intestinal obstruction (1,888 drugs)

Browse all the conditions that are associated with Intestinal obstruction:

Intestinal obstruction (2,614 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on paliperidone (the active ingredients of Invega) and Invega (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.